In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...

Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...

Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

The firm said the FDA lifted its clinical hold on its COVID/flu combo and standalone flu vaccine resuming plans to initiate Ph3 imminently. Q3 COVID vaccine revenues missed as expected, given delayed ...

Flu and COVID-19 shots are available by appointment at BCHD ... for whom it is still being given under Emergency Use Authorization from the FDA, the vaccine decreases the risk of hospitalization and ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

Novavax shares dropped Tuesday morning after the company slashed its full-year outlook when it announced its third-quarter results.

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

The U.S. vaccine maker now expects between $175 ... including an experimental COVID-flu combination shot, which Novavax said ...

NovaVax Inc.’s stock NVAX tumbled 7% early Tuesday, after the company cut its full-year guidance, offsetting a narrower-than-expected third-quarter loss and better-than-expected revenue. The company ...

The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...